Diabetes, Metabolic Syndrome and Obesity
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.5 | Q2 | 57.0% | 0.890 | Q2 | 80.7% |
| 2024 | 3.0 | Q2 | 52.8% | 0.827 | Q2 | 78.9% |
| 2023 | 2.8 | Q3 | 47.7% | 0.835 | Q2 | 81.0% |
| 2022 | — | — | 0.851 | Q2 | 82.2% | |
| 2021 | — | — | 0.685 | Q2 | 76.8% | |
| 2020 | — | — | 0.853 | Q2 | 81.5% | |
| 2019 | — | — | 0.862 | Q2 | 82.2% | |
| 2018 | — | — | 0.997 | Q1 | 84.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1178-7007
country
NZcoverage
2009-2026